Evidence map›Paper›PMID 33462790›Full record

ArticleJournal of neurovirology2021

Viral protein R polymorphisms in the pathogenesis of HIV-associated acute ischaemic stroke: a case-control study.

Kate McMullen, Kathleen Bateman, Alan Stanley, Marc Combrinck, Susan Engelbrecht, Alan Bryer

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurovirology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kate McMullenDivision of Neurology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa. mcmkat002@myuct.ac.za.ORCID 0000-0003-3579-3074
Kathleen BatemanDivision of Neurology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Alan StanleyDivision of Neurology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Marc CombrinckDivision of Geriatric Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
Susan EngelbrechtDivision of Medical Virology, Stellenbosch University and National Health Laboratory Services, Cape Town, South Africa.
Alan BryerDivision of Neurology, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.
University of Cape Town · ZANational Health Laboratory Service · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV-1 viral proteins have been implicated in endothelial dysfunction, which is a major determinant of ischaemic stroke risk in HIV-infected individuals. Polymorphisms in HIV-1 viral protein R (Vpr) may alter its potential to promote endothelial dysfunction, by modifying its effects on viral replication, reactivation of latent cells, upregulation of pro-inflammatory cytokines and infection of macrophages. We analysed Vpr polymorphisms and their association with acute ischaemic stroke by comparing Vpr signature amino acids between 54 HIV-infected individuals with acute ischaemic stroke, and 80 age-matched HIV-infected non-stroke controls. Isoleucine at position 22 and serine at position 41 were associated with ischaemic stroke in HIV. Individuals with stroke had lower CD4 counts and CD4 nadirs than controls. These polymorphisms are unique to individuals with stroke compared to South African subtype C and the control group consensus sequences. Signature Vpr polymorphisms are associated with acute ischaemic stroke in HIV. These may increase stroke risk by promoting endothelial dysfunction and susceptibility to opportunistic infections. Therapeutic targeting of HIV-1 viral proteins may present an additional mechanism of decreasing stroke risk in HIV-infected individuals.

Indexed as

AdultCase-Control StudiesFemaleHIV-1HIV InfectionsHumansIschemic StrokeMaleMiddle AgedPolymorphism, Single Nucleotidevpr Gene Products, Human Immunodeficiency Virusvpr Gene Products, Human Immunodeficiency Virusvpr protein, Human immunodeficiency virus 1HIVStrokeViral protein R

Identifiers

PMID33462790
OpenAlexW3121300328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.